Terms: = Ovarian cancer AND TFE3, RCCP2, 7030, ENSG00000068323, TFEA
12 results:
1. tfe3 nuclear expression as a novel biomarker of ovarian sclerosing stromal tumors and associated with its histological morphology.
Zhao L; Yang Z; Zhou Y; Liu Y; Luo Q; Jiang Q; Wang H; Wang N
J Ovarian Res; 2023 Aug; 16(1):152. PubMed ID: 37528481
[TBL] [Abstract] [Full Text] [Related]
2. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
Lancet Oncol; 2022 Mar; 23(3):382-392. PubMed ID: 35123662
[TBL] [Abstract] [Full Text] [Related]
3. Renal cell tumor with sex-cord/gonadoblastoma-like features: analysis of 6 cases.
Wang G; Amin MB; Grossmann P; Ptáková N; Hayes M; Hartmann A; Agaimy A; Lopez JI; Michal M; Hes O
Virchows Arch; 2022 Feb; 480(2):349-358. PubMed ID: 34775513
[TBL] [Abstract] [Full Text] [Related]
4. Case Report: Ectopic Adrenocortical Carcinoma in the Ovary.
Tsai WH; Chen TC; Dai SH; Zeng YH
Front Endocrinol (Lausanne); 2021; 12():662377. PubMed ID: 33815299
[TBL] [Abstract] [Full Text] [Related]
5. Gene of the month: TFE 3.
Pinto K; Chetty R
J Clin Pathol; 2020 Nov; 73(11):691-694. PubMed ID: 32820043
[TBL] [Abstract] [Full Text] [Related]
6. Predictive biomarkers of platinum and taxane resistance using the transcriptomic data of 1816 ovarian cancer patients.
Fekete JT; Ősz Á; Pete I; Nagy GR; Vereczkey I; Győrffy B
Gynecol Oncol; 2020 Mar; 156(3):654-661. PubMed ID: 31973910
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathological Characteristics of ovarian Sclerosing Stromal Tumor with an Emphasis on tfe3 Overexpression.
Park CK; Kim HS
Anticancer Res; 2017 Oct; 37(10):5441-5447. PubMed ID: 28982854
[TBL] [Abstract] [Full Text] [Related]
8. Rhabdoid Myomelanocytic Tumor (PEComa) of the Ovary: A Clinically Benign Case Followed for 7 Years.
Rampisela D; Grossmann P; Donner LR
Int J Surg Pathol; 2016 Aug; 24(5):431-5. PubMed ID: 26944064
[TBL] [Abstract] [Full Text] [Related]
9. Melanotic Xp11 translocation renal cancer: report of a case with a unique intratumoral sarcoid-like reaction.
Ritterhouse LL; Cykowski MD; Hassell LA; Slobodov G; Bane BL
Diagn Pathol; 2014 Apr; 9():81. PubMed ID: 24735727
[TBL] [Abstract] [Full Text] [Related]
10. Melanotic xp11.2 neoplasm of the ovary: report of a unique case.
LeGallo RD; Stelow EB; Sukov WR; Duska LR; Alisanski SB; Folpe AL
Am J Surg Pathol; 2012 Sep; 36(9):1410-4. PubMed ID: 22895274
[TBL] [Abstract] [Full Text] [Related]
11. Value of FDG PET/CT in patients with treated ovarian cancer and raised CA125 serum levels.
Palomar A; Nanni C; Castellucci P; Ambrosini V; Montini GC; Allegri V; Pettinato C; Al-Nahhas A; Soriano A; Grassetto G; Rubello D; Fanti S
Mol Imaging Biol; 2012 Feb; 14(1):123-9. PubMed ID: 21240639
[TBL] [Abstract] [Full Text] [Related]
12. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer.
Sunde JS; Donninger H; Wu K; Johnson ME; Pestell RG; Rose GS; Mok SC; Brady J; Bonome T; Birrer MJ
Cancer Res; 2006 Sep; 66(17):8404-12. PubMed ID: 16951150
[TBL] [Abstract] [Full Text] [Related]
